Targeting neuroinflammation through reductions in the levels of these cytokines can be achieved by inhibiting JNK signaling, which plays an important role in Alzheimer’s disease by regulating Aβ production [68,69]. This evidence concerns the gene MAPK8 and Alzheimer disease.